Novartis touts older cancer drug for MS in attack on Roche's Ocrevus
Reuters
URL: https://www.reuters.com/article/us-nova ... SKBN2330KV
Category: healthNews
Published: Wed, 27 May 2020 02:06:47 -0400
Description: Novartis said on Wednesday that an older leukaemia drug it is re-purposing for multiple sclerosis halted disease activity in many patients during the first two years of injections as the Swiss drugmaker takes aim at Roche's lucrative Ocrevus infusion.